Clinical Trial Update: Rocklatan Retinal Perfusion OCT Study [Phase 4]

View source ↗

Summary

Update on a Phase 4 Rocklatan retinal perfusion OCT study for glaucoma; the trial is currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• ROCKLATAN (Netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Glaucoma | Phase 4 | Status: NOT_YET_RECRUITING